Skip to main content

gadobutrol

NDC 70436-217 · Slate Run Pharmaceuticals, LLC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic namegadobutrol
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)GADOBUTROL
Strength604.72 mg/mL
Pharmacologic classGadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]
Marketing categoryANDA

Packages

70436-217-50 — 1 VIAL, MULTI-DOSE in 1 CARTON (70436-217-50) / 65 mL in 1 VIAL, MULTI-DOSE (70436-217-78)

70436-217-80 — 1 VIAL, MULTI-DOSE in 1 CARTON (70436-217-80) / 65 mL in 1 VIAL, MULTI-DOSE (70436-217-38)

Billed under HCPCS

A9585 — Injection, gadobutrol, 0.1 ml Medicare Part B payment limit (ASP + 6%): $0.26

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42337-005 — gadobutrol, 42337-006 — gadobutrol, 42337-007 — gadobutrol, 50419-325 — gadobutrol, 65219-281 — Gadobutrol, 65219-287 — Gadobutrol, 65219-289 — Gadobutrol, 70436-212 — gadobutrol, 70436-213 — gadobutrol, 70436-214 — gadobutrol, 70436-216 — gadobutrol, 70436-218 — gadobutrol, 70710-2064 — gadobutrol, 70710-2065 — gadobutrol, 70710-2066 — gadobutrol

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.